Navigation Links
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Merrill Lynch Conference
Date:2/4/2008

ROCKVILLE, Md., Feb. 4 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) announced today that its presentation at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference will be webcast and may be accessed at http://www.hgsi.com

(Logo: http://www.newscom.com/cgi-bin/prnh/20010612/HGSLOGO )

A member of Human Genome Sciences' senior management team will present an overview of the company on Wednesday, February 6, 2008 at 2:20 pm Eastern Time.

Investors interested in listening to the live webcast should log on before the start time in order to download any software required. The archive of the webcast will be available for several days after the live event.

The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs.

HGS and Human Genome Sciences are registered trademarks of Human Genome Sciences, Inc. For additional information on Human Genome Sciences, Inc., visit the company's web site at http://www.hgsi.com.


'/>"/>
SOURCE Human Genome Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Stemagen First to Create Cloned Human Embryos From Adult Cells
2. EVICEL(TM) Fibrin Sealant (Human) Approved for General Hemostasis in Surgery
3. International team identifies 480 genes that control human cell division
4. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JPMorgan Conference
5. Department of Health & Human Services Names Dr. Eric Rose to National Biodefense Science Board
6. Human Genome Sciences and Aegera Therapeutics Announce Licensing and Collaboration Agreement on Novel Anti-Cancer Drugs
7. Human Genome Sciences Initiates Second Randomized Phase 2 Trial of HGS-ETR1 in Combination With Chemotherapy
8. Human Genome Sciences to Sponsor Conference Call
9. Lethal Human H5N1 Influenza Virus Replikin Gene Still Upregulated
10. The closest look ever at native human tissue
11. International Human Rights Day Recognized by Terasem Movement, Inc.s Third Annual Colloquium on the Law of Transbeman Persons
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... ... May 22, 2017 , ... Cancer diagnostics and pathology ... B2 at the Association for Pathology Informatics Annual Summit at the ... demonstrating its Cancer Diagnostic Cockpit and Consultation Portal, Inspirata will present research it ...
(Date:5/18/2017)... ... May 18, 2017 , ... Dr. Ralph ... at the Prince Of Wales Private Hospital. The procedure was performed on a ... patient failed conservative treatments prior to undergoing surgery. , The AxioMed viscoelastic disc ...
(Date:5/18/2017)... ... May 17, 2017 , ... Cognition ... and commercialization, has just released version 9.0 of the Cognition Cockpit platform. , ... of Cockpit,” says David Cronin, CEO of Cognition. “We’re thrilled to finally be ...
(Date:5/18/2017)... ... May 18, 2017 , ... When James Sherley, was notified earlier this year that his company ... the Year 2017 by The Silicon Review , he was not surprised as others ... Asymmetrex’s value, but this recognition by Silicon Valley was particularly meaningful. Our selection ...
Breaking Biology Technology:
(Date:4/11/2017)... -- Research and Markets has announced the addition of ... offering. ... market to grow at a CAGR of 30.37% during the period ... has been prepared based on an in-depth market analysis with inputs ... growth prospects over the coming years. The report also includes a ...
(Date:4/5/2017)... 5, 2017  The Allen Institute for Cell Science ... a one-of-a-kind portal and dynamic digital window into the ... the first application of deep learning to create predictive ... lines and a growing suite of powerful tools. The ... and future publicly available resources created and shared by ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
Breaking Biology News(10 mins):